Long COVID Web: Clinical Trials Update—Long COVID, POTS, RECOVER-Autonomic & Argenx

Clinical Trials Update: Long COVID, POTS & RECOVER-Autonomic + Argenx Studies Long COVID Web’s Webinar Series presents an in-depth clinical trials update exploring emerging research on Long COVID and Postural Orthostatic Tachycardia Syndrome (POTS). Featured Presentations: RECOVER-Autonomic Clinical Trial Update An overview of the multicenter RECOVER-Autonomic trial focused on Long COVID complicated by POTS. This session explores the effects of ivabradine, IVIG (intravenous immunoglobulin), and both supervised and unsupervised non-pharmacological interventions. Speaker: Peter Novak, MD, PhD Associate Professor of Neurology Mass General Brigham, Boston, MA Efgartigimod for Post-COVID POTS (Argenx Study) A comprehensive review of the Phase II clinical trial evaluating the efficacy and safety of efgartigimod in adults with post-COVID-onset POTS. As the first FDA-regulated, multicenter, double-blind randomized controlled trial for POTS, this presentation also highlights key findings and implications for future treatment development. Speaker: Tae Chung, MD Director, Johns Hopkins POTS Clinic Program Associate Professor of PM&R and Neurology Johns Hopkins University, Baltimore, MD